[go: up one dir, main page]

WO2003069343A3 - Procede de detection dans les selles des marqueurs tumoraux cea, ca19.9 ou ca72.4 pour reconnaitre des tumeurs gastro-intestinales - Google Patents

Procede de detection dans les selles des marqueurs tumoraux cea, ca19.9 ou ca72.4 pour reconnaitre des tumeurs gastro-intestinales Download PDF

Info

Publication number
WO2003069343A3
WO2003069343A3 PCT/EP2003/001504 EP0301504W WO03069343A3 WO 2003069343 A3 WO2003069343 A3 WO 2003069343A3 EP 0301504 W EP0301504 W EP 0301504W WO 03069343 A3 WO03069343 A3 WO 03069343A3
Authority
WO
WIPO (PCT)
Prior art keywords
stool
tumor markers
detection
gastrointestinal tumors
allowing diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2003/001504
Other languages
German (de)
English (en)
Other versions
WO2003069343A2 (fr
Inventor
Hans Scheefers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ScheBo Biotech AG
Original Assignee
ScheBo Biotech AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ScheBo Biotech AG filed Critical ScheBo Biotech AG
Priority to AU2003210274A priority Critical patent/AU2003210274A1/en
Publication of WO2003069343A2 publication Critical patent/WO2003069343A2/fr
Anticipated expiration legal-status Critical
Publication of WO2003069343A3 publication Critical patent/WO2003069343A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

La présente invention concerne un procédé de détection qualitative et/ou quantitative de CEA, CA19.9, CA72.4 ou de parties de ceux-ci, qui servent de marqueurs tumoraux dans les selles humaines ou animales pour mettre en évidence une affection maligne dans le tube gastro-intestinal et dans la cavité abdominale (oesophage, estomac, intestin grêle, voies biliaires, pancréas et gros intestin).
PCT/EP2003/001504 2002-02-14 2003-02-14 Procede de detection dans les selles des marqueurs tumoraux cea, ca19.9 ou ca72.4 pour reconnaitre des tumeurs gastro-intestinales Ceased WO2003069343A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003210274A AU2003210274A1 (en) 2002-02-14 2003-02-14 Method for the detection of tumor markers cea, ca19.9, or ca72.4 in the stool, allowing diagnosis of gastrointestinal tumors

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10206056 2002-02-14
DE10206056.8 2002-02-14

Publications (2)

Publication Number Publication Date
WO2003069343A2 WO2003069343A2 (fr) 2003-08-21
WO2003069343A3 true WO2003069343A3 (fr) 2004-12-23

Family

ID=27674624

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/001504 Ceased WO2003069343A2 (fr) 2002-02-14 2003-02-14 Procede de detection dans les selles des marqueurs tumoraux cea, ca19.9 ou ca72.4 pour reconnaitre des tumeurs gastro-intestinales

Country Status (2)

Country Link
AU (1) AU2003210274A1 (fr)
WO (1) WO2003069343A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007071366A1 (fr) * 2005-12-21 2007-06-28 Roche Diagnostics Gmbh Méthode d'évaluation du cancer colorectal par mesure de l'hémoglobine et de la pyruvate-kinase m2 dans un echantillon de selles
DE202012012084U1 (de) 2012-07-09 2013-04-15 Schebo Biotech Ag Testkit (Kombi-Schnelltest) zum synchronen Nachweis von Biomarkern im Stuhl zur Erkennung pathologischer Veränderungen im Gastrointestinaltrakt, insbesondere im Darm
DE102012013888A1 (de) 2012-07-09 2014-05-22 Schebo Biotech Ag Testkit (Kombi-Schnelltest) zum synchronen Nachweis von Biomarkern im Stuhl zur Erkennung pathologischer Veränderungen im Gastrointestinaltrakt, insbesondere im Darm
DE102016015060A1 (de) 2016-12-19 2018-03-29 Schebo Biotech Ag Verfahren zum Nachweis von Tumormarkern im Stuhl zur Erkennung gastrointestinaler Tumore
DE102018000815A1 (de) 2018-02-01 2019-08-01 Schebo Biotech Ag Verfahren zum Nachweis von Biomarkern im Stuhl zur Erkennung von Erkrankungen des Intestinaltraktes

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4467031A (en) * 1981-08-21 1984-08-21 Hoffmann-La Roche Inc. Enzyme-immunoassay for carcinoembryonic antigen
US4818709A (en) * 1983-01-21 1989-04-04 Primus Frederick J CEA-family antigens, Anti-CEA antibodies and CEA immunoassay
US5380647A (en) * 1991-02-05 1995-01-10 Farrokh Saidi Simple test for detecting carcinoembryonic antigen in stool
US6331402B1 (en) * 1998-06-26 2001-12-18 Roche Diagnostics Gmbh Reduction of interference of immunoassays by substances derived from the framework regions of antibodies

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4467031A (en) * 1981-08-21 1984-08-21 Hoffmann-La Roche Inc. Enzyme-immunoassay for carcinoembryonic antigen
US4818709A (en) * 1983-01-21 1989-04-04 Primus Frederick J CEA-family antigens, Anti-CEA antibodies and CEA immunoassay
US5380647A (en) * 1991-02-05 1995-01-10 Farrokh Saidi Simple test for detecting carcinoembryonic antigen in stool
US6331402B1 (en) * 1998-06-26 2001-12-18 Roche Diagnostics Gmbh Reduction of interference of immunoassays by substances derived from the framework regions of antibodies

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
HENSLEE J G ET AL: "IDENTIFICATION AND CHARACTERIZATION OF NEW ANTIGENIC FRAGMENTS RELATED TO CARCINOEMBRYONIC ANTIGEN IN ADULT FECES", CANCER RESEARCH, vol. 52, no. 15, 1992, pages 4175 - 4182, XP001155542, ISSN: 0008-5472 *
KUROKI M ET AL: "REACTION PROFILES OF SEVEN ENZYME IMMUNOASSAY KITS FOR CARCINOEMBRYONIC ANTIGEN CEA ANALYZED WITH PURIFIED PREPARATIONS OF CEA AND RELATED NORMAL ANTIGENS", CLINICAL BIOCHEMISTRY, vol. 25, no. 1, 1992, pages 29 - 35, XP009018874, ISSN: 0009-9120 *
MEI YUAN ET AL: "Fecal detection of tumor-associated antigen S-Tn Tn and CEA in the diagnosis of gastric cancer", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL, vol. 35, no. 0, 1994, 85th Annual Meeting of the American Association for Cancer Research;San Francisco, California, USA; April 10-13, 1994, 1994, pages 526, XP001155541, ISSN: 0197-016X *
NUNEZ GILDA ET AL: "Enzyme immunoassay to detect carcinoembryonic antigen in human fecal feces", BIOTECNOLOGIA APLICADA, vol. 11, no. 2, 1994, pages 180 - 184, XP009018884 *
STUBBS R S ET AL: "Faecal carcinoembryonic antigen in colorectal cancer patients.", GUT. ENGLAND AUG 1986, vol. 27, no. 8, August 1986 (1986-08-01), pages 901 - 905, XP009018889, ISSN: 0017-5749 *
SUGANO K ET AL: "DETECTION OF INCREASED STOOL CEA AND ITS CHARACTERIZATION AS A MEMBRANE-BOUND FORM IN COLORECTAL CARCINOMA AND OTHER GI TRACT DISORDERS", TUMOR BIOLOGY, vol. 11, no. 1-2, 1990, XVIITH MEETING OF THE INTERNATIONAL SOCIETY FOR ONCODEVELOPMENTAL BIOLOGY AND MEDICINE, FREIBURG, WE, pages 70, XP009018875, ISSN: 1010-4283 *

Also Published As

Publication number Publication date
WO2003069343A2 (fr) 2003-08-21
AU2003210274A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
WO2005001092A3 (fr) Compositions et procedes pour diagnostiquer et traiter le cancer
EP3064584A3 (fr) Procédés à base de microarn et compositions pour le diagnostic, pronostic et traitement du cancer gastrique
WO2005122915A3 (fr) Appareil et methodes d'execution d'interventions gastro-intestinales transluminales
AU2003299934A8 (en) Implantable digestive tract organ
EP2468891A3 (fr) Procédés à base de micro ARN et compositions pour le diagnostic et le traitement des cancers solides
ZA200409492B (en) Compositions and methods for the diagnosis and treatment of tumor.
WO2006064451A3 (fr) Agents de contraste de ciblage ou agents therapeutiques de ciblage destines a une imagerie et a une therapie moleculaires
PH12015501744B1 (en) Therapeutic and diagnostic target for cancer comprising dll3 binding reagents
WO2005013800A3 (fr) Activite elevee du mecanisme hedgehog dans des tumeurs du systeme digestif, et methodes de traitement de tumeurs du systeme digestif presentant une activite elevee du mecanisme hedgehog
EP2275544A3 (fr) Gènes et polypeptides en rapport avec les cancers du colon chez l'homme
WO2004060302A3 (fr) Methodes et compositions pour le diagnostic, le pronostic, et le traitement du cancer
BRPI0513896A (pt) método para a discriminação entre tecido saudável e de tumor
IL155611A0 (en) Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
WO2005123993A3 (fr) Profilage micromatriciel bactériophage de la réponse humorale à la maladie
AU2003280991A8 (en) Method for diagnosis of intestinal-type gastric tumors
EP1989552A4 (fr) Marqueurs protéiques destinés à diagnostiquer un cancer de l'estomac et nécessaire de diagnostic les utilisant
AU2003303379A1 (en) Androgen-regulated genes and uses for diagnosis, prognosis and treatment of prostate neoplastic conditions
WO2003069343A3 (fr) Procede de detection dans les selles des marqueurs tumoraux cea, ca19.9 ou ca72.4 pour reconnaitre des tumeurs gastro-intestinales
WO2005094348A3 (fr) Anticorps anti-lfl2 pour le diagnostic, le pronostic et le traitement d'un cancer
AU2003245927A1 (en) Target genes for the diagnosis and treatment of cancer
WO2006017573A3 (fr) Procede pour la detection precoce du cancer du pancreas et d'autres etats pathologiques gastro-intestinaux
WO2001004343A3 (fr) Procede permettant d'etablir un pronostic pour des patients atteints d'un cancer, par mesure des niveaux d'expression de la proteine bag
WO2006052975A3 (fr) Tumeurs de mdl-1 et procedes associes
ZA200703482B (en) B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
WO2004033641A3 (fr) Profilage de l'expression genique du cancer de la vessie

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP